In addition, flow cytometry showed that a significantly higher proportion of CD11b+CD11c+ DC in the tumor of 4T1-CXCL13-2 group, compared to the 4T1 and 4T1-PCDH groups (Fig. 5C, D). The gene discussed is CXCL13; the disease is neoplasm.